Acuity Law advises on the £894,000 investment in Hexigone Inhibitors Limited

Print Friendly, PDF & Email

Acuity Law advises on the £894,000 investment in Hexigone Inhibitors Limited

Key Contact: Phil Pugh

Acuity Law is pleased to have advised on the £894,000 investment in Hexigone Inhibitors Limited – an expanding corrosion technology firm based in South Wales.

Hexigone is a manufacturing start-up that offers sustainable corrosion inhibitors across the corrosion industry. Acuity Law advised Hexigone on the investment from the British Business Bank Future Fund as well as investment from new enterprise investment scheme investors and existing investors such as the Development Bank of Wales. The investment is an excellent milestone and will see the company go from strength to strength through its expansion and scale-up of its manufacturing business.

Patrick Dodds, CEO and Founder of Hexigone, commented as follows: “The Acuity team helped Hexigone from the outset of the transaction and guided the company through the different elements of the investment. Phil, Chiara and Elena were proactive and on hand to support the company throughout the process to ensure a smooth and successful completion.”

Corporate partner Phil Pugh led the transaction, with support from Chiara Howfield and Elena Visser.

If you would like any information or guidance on investment in your company, please get in touch with our Corporate Team today.

Recent Posts

Social Media Icons
A Tale Of Two Tweets (And A Facebook Post)
February 3, 2023
novel vgc
Acuity Law Advises Novel On Investment From VGC Partners
February 2, 2023
court of appeal
Coronavirus Not a ‘Serious and Imminent Threat’ To Justify AWOL Employee
January 27, 2023
eu flags
Retain, Revoke, or Reform? The Uncertain Fate of EU Employment Law
January 27, 2023
flexible working
Flexibility From Day One
January 27, 2023
nhs
A Meaningful & Genuine Redundancy Process: Mogane v Bradford Teaching NHS Foundation Trust
January 27, 2023

Archives

Categories

Skip to content